Psychosocial characteristics of alcoholic and non-alcoholic liver disease recipient candidates in liver transplantation: a prospective observational study

QR Code

Psychosocial characteristics of alcoholic and non-alcoholic liver disease recipient candidates in liver transplantation: a prospective observational study

Abstract Background There are long-standing controversies about the transplant indications for alcoholic liver disease (ALD), because of the recognition that ALD is fundamentally self-inflicted. However, it is unclear whether psychosocial characteristics of ALD are different from that of non-alcohol...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Masato Shizuku, Hiroyuki Kimura, Hideya Kamei, Shinichi Kishi, Tatsuya Tokura, Nobuhiko Kurata, Kanta Jobara, Atsushi Yoshizawa, Chisato Tsuboi, Naoko Yamaguchi, Midori Kato, Keita Kawai, Makoto Yamashiki, Emi Kanai, Kanako Ishizuka, Norio Ozaki, Yasuhiro Ogura
Format:	article
Langue:	EN
Publié:	BMC 2021
Sujets:	Liver transplantation Alcoholic liver disease Alcohol dependence Psychosocial functioning Personality Social support Diseases of the digestive system. Gastroenterology RC799-869
Accès en ligne:	https://doaj.org/article/fd0d6f6267ed4e48b4b5df18fcfe29e5
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Alcohol-induced liver disease: From molecular damage to treatment
par: Fernández Checa,José C, et autres
Publié: (2002)

Causes of death in patients with Non-alcoholic Fatty Liver Disease (NAFLD), alcoholic liver disease and chronic viral Hepatitis B and C
par: Pegah Golabi, et autres
Publié: (2022)

Body Mass Index and Indicators of Lipid Exchange in Liver Steatosis of Alcoholic and Nonalcoholic Genesis in Residents of Rural Area: Similarities and Differences
par: N. V. Mikhaylova, et autres
Publié: (2019)

Non-Alcoholic Fatty Liver Disease and Hypothyroidism: Review of Clinical and Experimental Studies
par: Tetiana Ranhulova
Publié: (2021)

Accumulation of Genetic and Epigenetic Alterations in the Background Liver and Emergence of Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease
par: Satoru Hagiwara, et autres
Publié: (2021)

Effect of albumin on indicators of systemic inflammation and endothelial dysfunction in patients with alcoholic liver cirrhosis in combination with obesity
par: N.H. Virstiuk, et autres
Publié: (2020)

Non-invasive Diagnostics of Liver Fibrosis
par: Mihaylov R., et autres
Publié: (2017)

Diagnostic significance of clinical and laboratory indices in predicting non-alcoholic fatty liver disease during screening studies
par: Aleksandr E. Nosov, et autres
Publié: (2021)

Diagnostics and treatment of non-alcoholic fatty liver disease with concomitant asthenic syndrome
par: Aleksandr I. Pavlov, et autres
Publié: (2021)

Astragalus Polysaccharides and Saponins Alleviate Liver Injury and Regulate Gut Microbiota in Alcohol Liver Disease Mice
par: Jingxuan Zhou, et autres
Publié: (2021)

Activation and Functional Priming of Blood Neutrophils in Non-Alcoholic Fatty Liver Disease Increases in Non-Alcoholic Steatohepatitis
par: Lauszus JS, et autres
Publié: (2021)

Non-Alcoholic Fatty Liver Disease as a Risk for Colorectal Cancer Development and the Role of Screening Colonoscopy in Clinical Practice
par: Cosmas Rinaldi Adithya Lesmana, et autres
Publié: (2019)

NADH and NRH as potential dietary supplements or pharmacological agents for early liver injury caused by acute alcohol exposure
par: Ke Wu, et autres
Publié: (2021)

Gut non-bacterial microbiota contributing to alcohol-associated liver disease
par: Wenkang Gao, et autres
Publié: (2021)

Verapamil induces autophagy to improve liver regeneration in non-alcoholic fatty liver mice
par: Jian-Lin Lai, et autres
Publié: (2021)

Current concepts of the pathogenesis of non-alcoholic fatty liver disease
par: Evgenia Pavlovna Kosobyan, et autres
Publié: (2010)

The negative and detrimental effects of high fructose on the liver, with special reference to metabolic disorders
par: Mai BH, et autres
Publié: (2019)

Zinc as a Drug for Wilson’s Disease, Non-Alcoholic Liver Disease and COVID-19-Related Liver Injury
par: Pierpaolo Coni, et autres
Publié: (2021)

Adiponutrin and Adiponectin Gene Variants in Indonesian Patients with Non-Alcoholic Fatty Liver Disease: a Preliminary Study
par: Rayvita AN Meagratia, et autres
Publié: (2021)

The Contribution of Dietary Fructose to Non-alcoholic Fatty Liver Disease
par: Siyu Yu, et autres
Publié: (2021)

Clinical and Metabolic Characteristics of Non-Alcoholic Fatty Liver Disease Patients in Saudi Arabia: Data from the Systematic Observatory Liver Disease (SOLID) Registry
par: Alswat K, et autres
Publié: (2021)

NON-ALCOHOLIC STEATOHEPATITIS IN CHILDREN − A PRACTICAL APPROACH WITH CASE REPORT
par: Ana Šinkovec, et autres
Publié: (2021)

Involvement of Ceramides in Non-Alcoholic Fatty Liver Disease (NAFLD) Atherosclerosis (ATS) Development: Mechanisms and Therapeutic Targets
par: Daniela Maria Tanase, et autres
Publié: (2021)

Alcohol and alcoholism

Association of Cholecystectomy With Liver Fibrosis and Cirrhosis Among Adults in the USA: A Population-Based Propensity Score-Matched Study
par: Zhi-Qin Xie, et autres
Publié: (2021)

Astragaloside IV Alleviates Liver Inflammation, Oxidative Stress and Apoptosis to Protect Against Experimental Non-Alcoholic Fatty Liver Disease
par: Liang XY, et autres
Publié: (2021)

Alcohol and alcoholism.
Publié: (1987)

PRESENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS OF UNCONTROLLED AND CONTROLLED TYPE 2 DIABETES MELLITUS
par: Aqeela Rashid, et autres
Publié: (2019)

Non-Alcoholic Fatty Liver Disease (NAFLD) and Potential Links to Depression, Anxiety, and Chronic Stress
par: Sue Shea, et autres
Publié: (2021)

Effect of Saxagliptin, a Dipeptidyl Peptidase 4 Inhibitor, on Non-Alcoholic Fatty Liver Disease
par: Chen L, et autres
Publié: (2020)

Alcohol-Attributable Fraction in Liver Disease: Does GDP Per Capita Matter?
par: Paul T. Kröner, et autres
Publié: (2016)

Foresight regarding drug candidates acting on the succinate–GPR91 signalling pathway for non-alcoholic steatohepatitis (NASH) treatment
par: Chengyuan Liang, et autres
Publié: (2021)

Aryl Hydrocarbon Receptor Deficiency in Intestinal Epithelial Cells Aggravates Alcohol-Related Liver DiseaseSummary
par: Minyi Qian, et autres
Publié: (2022)

The Role of Notch Signaling Pathway in Non-Alcoholic Fatty Liver Disease
par: Hao Xu, et autres
Publié: (2021)

High-Normal Serum Thyrotropin Levels Increased the Risk of Non-Alcoholic Fatty Liver Disease in Euthyroid Subjects with Type 2 Diabetes
par: Tan Y, et autres
Publié: (2021)

Obesity and nonalcoholic fatty liver disease: current perspectives
par: Sarwar R, et autres
Publié: (2018)

Black soybean-derived peptides exerted protective effect against alcohol-induced liver injury in mice
par: Jian Ren, et autres
Publié: (2021)

Impact of Genetic Polymorphism on Response to Therapy in Non-Alcoholic Fatty Liver Disease
par: José Ignacio Martínez-Montoro, et autres
Publié: (2021)

Investigating the effect of Crocus sativus L. petal hydroalcoholic extract on inflammatory and enzymatic indices resulting from alcohol use in kidney and liver of male rats
par: Azizi M, et autres
Publié: (2019)

Effects of naringenin supplementation in overweight/obese patients with non-alcoholic fatty liver disease: study protocol for a randomized double-blind clinical trial
par: Fatemeh Naeini, et autres
Publié: (2021)